Ledger.Open graph →

SEC Form D · Amendment · filed October 14, 2021

Reactive Medical Labs Inc

Offering

$2.0M

Sold

$732K

Exemption

Rule 506(b)

Industry

Biotechnology

Location

Davis, CA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Yi Guo · Weehawken, NJDirector John P. Alexander · Carol Stream, ILExec · Director Braeden Lichti · Davis, CAExec · Director David D. Dantzker · Princeton, NJDirector Jerome B. Korten · Princeton, NJExec · Director R. E. Emrich · Atlanta, GAExec · Director Ryan E. Forry · Atlanta, GADirector Hatem Abou-Sayed · San Diego, CAExec · Director Mark S. Kripke · Atlanta, GAExec · Director Graydon Bensler · Vancouver, British Columbia, CanadaExec · Director Mark E. Sear · LOS ANGELES, CAExec · Director Lindsay A. Rosenwald · Waltham, MAExec · Director Jordan Plews · Sacramento, CAExec · Director Scott A. Boilen · Waltham, MAExec · Director John D. Fernandes · Princeton, NJExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗